Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
BackgroundImmunogenic cell death (ICD) is a form of cell death that elicits immune responses against the antigens found in dead or dying tumor cells. Growing evidence implies that ICD plays a significant role in triggering antitumor immunity. The prognosis for glioma remains poor despite many biomar...
Main Authors: | Yirui Kuang, Bincan Jiang, Hecheng Zhu, Yi Zhou, Haoxuan Huang, Can Li, Wenlong Zhang, Xuewen Li, Yudong Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1102094/full |
Similar Items
-
Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
by: Zhen Kang, et al.
Published: (2023-06-01) -
Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma
by: Yao Zhou, et al.
Published: (2023-12-01) -
Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
by: Xiaoyue Ren, et al.
Published: (2023-08-01) -
Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery
by: Xin Yin, et al.
Published: (2023-10-01) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)